Viemed Healthcare (NASDAQ:VMD) President Sells $297,389.40 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) President Michael Moore sold 31,570 shares of the firm’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $9.42, for a total value of $297,389.40. Following the transaction, the president owned 1,691,044 shares in the company, valued at approximately $15,929,634.48. This trade represents a 1.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Michael Moore also recently made the following trade(s):

• On Friday, March 20th, Michael Moore sold 65,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $8.77, for a total value of $570,050.00.
• On Thursday, March 19th, Michael Moore sold 40,232 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.21, for a total transaction of $370,536.72.

Viemed Healthcare Stock Performance

Shares of NASDAQ:VMD opened at $8.71 on Monday. The firm’s 50 day simple moving average is $8.30 and its 200 day simple moving average is $7.37. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $10.06. The company has a market capitalization of $336.21 million, a price-to-earnings ratio of 23.54 and a beta of 1.23. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.18 and a quick ratio of 1.06.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. The firm had revenue of $76.18 million during the quarter, compared to analysts’ expectations of $77.70 million. Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%.

Hedge Funds Weigh In On Viemed Healthcare

Hedge funds have recently made changes to their positions in the business. Forager Capital Management LLC raised its holdings in shares of Viemed Healthcare by 12.1% in the second quarter. Forager Capital Management LLC now owns 2,136,472 shares of the company’s stock valued at $14,763,000 after purchasing an additional 230,670 shares during the last quarter. Wasatch Advisors LP boosted its holdings in Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock worth $10,683,000 after purchasing an additional 240,346 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Viemed Healthcare by 3.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock valued at $10,751,000 after purchasing an additional 49,962 shares in the last quarter. Geode Capital Management LLC grew its position in Viemed Healthcare by 2.0% in the second quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock valued at $5,519,000 after purchasing an additional 15,353 shares in the last quarter. Finally, State Street Corp increased its stake in Viemed Healthcare by 1.7% in the 4th quarter. State Street Corp now owns 675,190 shares of the company’s stock valued at $5,017,000 after buying an additional 11,385 shares during the last quarter. 74.24% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on VMD. Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Zacks Research upgraded Viemed Healthcare to a “hold” rating in a report on Thursday, January 8th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Viemed Healthcare has an average rating of “Hold”.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.